Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma

NCT02704767 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Apatinib
DRUG: Tarceva
DRUG: Placebo

Sponsor

First Affiliated Hospital of Kunming Medical University